Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Lutz

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
European Journal of Haematology|August 12, 2017
Mesenchymal stromal cells contribute to quiescence of therapy-resistant leukemic cells in acute myeloid leukemiaWenwen Wang, Tilmann Bochtler, Patrick Wuchter, et al.
Leukemia & Lymphoma|October 14, 2016
Hematopoietic stem cells can be separated from leukemic cells in a subgroup of adult acute lymphoblastic leukemia patientsWenwen Wang, Elena Foerner, Eike Buss, et al.
Blood|April 19, 2003
Ex vivo targeting of p21Cip1/Waf1 permits relative expansion of human hematopoietic stem cellsSebastian Stier, Tao Cheng, Randolf Forkert, et al.
Molecular and Cellular Probes|October 29, 2003
The use of suppression subtractive hybridization for the study of SDF-1alpha induced gene-expression in human endothelial cellsThomas Neuhaus, Christoph Lutz, Sebastian Stier, et al.
International Journal of Cancer|June 5, 2014
Targeting CDK9 by wogonin and related natural flavones potentiates the anti-cancer efficacy of the Bcl-2 family inhibitor ABT-263Gernot Polier, Marco Giaisi, Rebecca Köhler, et al.
GMS Journal for Medical Education|October 31, 2022
Curricular course for medical students at a hematology and oncology specialty practice, 2010-2022Rudolf Weide, Jörg Thomalla, Christoph van Roye, et al.
The Journal of Experimental Medicine|June 2, 2005
Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool sizeSebastian Stier, Yon Ko, Randolf Forkert, et al.
Leukemia & Lymphoma|January 17, 2018
The molecular signature of AML with increased ALDH activity suggests a stem cell originRachel Blume, Eugen Rempel, Linda Manta, et al.
International Journal of Cancer|January 7, 2021
Analysis of nonleukemic cellular subcompartments reconstructs clonal evolution of acute myeloid leukemia and identifies therapy-resistant preleukemic clonesBorhan R Saeed, Linda Manta, Simon Raffel, et al.
International Journal of Cancer|December 30, 2014
The rarity of ALDH(+) cells is the key to separation of normal versus leukemia stem cells by ALDH activity in AML patientsVan T Hoang, Eike C Buss, Wenwen Wang, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
European Journal of Haematology|August 12, 2017
Mesenchymal stromal cells contribute to quiescence of therapy-resistant leukemic cells in acute myeloid leukemiaWenwen Wang, Tilmann Bochtler, Patrick Wuchter, et al.
Leukemia & Lymphoma|October 14, 2016
Hematopoietic stem cells can be separated from leukemic cells in a subgroup of adult acute lymphoblastic leukemia patientsWenwen Wang, Elena Foerner, Eike Buss, et al.
Blood|April 19, 2003
Ex vivo targeting of p21Cip1/Waf1 permits relative expansion of human hematopoietic stem cellsSebastian Stier, Tao Cheng, Randolf Forkert, et al.
Molecular and Cellular Probes|October 29, 2003
The use of suppression subtractive hybridization for the study of SDF-1alpha induced gene-expression in human endothelial cellsThomas Neuhaus, Christoph Lutz, Sebastian Stier, et al.
International Journal of Cancer|June 5, 2014
Targeting CDK9 by wogonin and related natural flavones potentiates the anti-cancer efficacy of the Bcl-2 family inhibitor ABT-263Gernot Polier, Marco Giaisi, Rebecca Köhler, et al.
GMS Journal for Medical Education|October 31, 2022
Curricular course for medical students at a hematology and oncology specialty practice, 2010-2022Rudolf Weide, Jörg Thomalla, Christoph van Roye, et al.
The Journal of Experimental Medicine|June 2, 2005
Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool sizeSebastian Stier, Yon Ko, Randolf Forkert, et al.
Leukemia & Lymphoma|January 17, 2018
The molecular signature of AML with increased ALDH activity suggests a stem cell originRachel Blume, Eugen Rempel, Linda Manta, et al.
International Journal of Cancer|January 7, 2021
Analysis of nonleukemic cellular subcompartments reconstructs clonal evolution of acute myeloid leukemia and identifies therapy-resistant preleukemic clonesBorhan R Saeed, Linda Manta, Simon Raffel, et al.
International Journal of Cancer|December 30, 2014
The rarity of ALDH(+) cells is the key to separation of normal versus leukemia stem cells by ALDH activity in AML patientsVan T Hoang, Eike C Buss, Wenwen Wang, et al.
Pageof 4